LifeMD (NASDAQ:LFMD) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 36.51 percent. This is a 119.05 percent decrease over earnings of $0.21 per share from the same period last year. The company reported quarterly sales of $46.868 million which beat the analyst consensus estimate of $46.848 million by 0.04 percent. This is a 27.06 percent decrease over sales of $64.255 million the same period last year.